CONSEQUENCES OF ANGIOGENESIS FOR TUMOR PROGRESSION, METASTASIS AND CANCER-THERAPY

被引:218
作者
RAK, JW
STCROIX, BD
KERBEL, RS
机构
[1] UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON, CANADA
[2] SUNNYBROOK HLTH SCI CTR, DIV CANC RES, TORONTO, ON M4N 3M5, CANADA
关键词
ANGIOGENESIS; CANCER THERAPY; METASTASIS; TUMOR PROGRESSION;
D O I
10.1097/00001813-199502000-00001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The growth of solid tumors to a clinically relevant size is dependent upon an adequate blood supply.(1) This is achieved by the process of tumor stroma generation where the formation of new capillaries is a central event.(1,2) Progressive recruitment of blood vessels to the tumor site and reciprocal support of tumor expansion by the resulting neovasculature are thought to result in a self-perpetuating loop helping to drive the growth of solid tumors.(3) The development of new vasculature also allows an 'evacuation route' for metastatically-competent tumor cells, enabling them to depart from the primary site and colonize initially unaffected organs.(4) Several molecular and cellular mechanisms have been identified by which tumor parenchyma may exert its angiogenic effect on host endothelial cells.(1-3,5-7) As a result of this paracrine influence, tumor-associated endothelial cells acquire an 'immature' phenotype(1) manifested by rapid proliferation, migration, release of proteases and expression of cytokines, endothelial-specific tyrosine kinases (e.g. flk-1, tek and others) as well as numerous other molecular alterations.(3) Consequently a network of structurally and functionally aberrant blood vessels is formed within the tumor mass.(8) There is also evidence that endothelial cells themselves, and likewise other stromal cells, may act reciprocally to alter the behavior of adjacent tumor cells in a paracrine or cell contact mediated fashion.(3) For example, production of interleukin 6(IL-6) by endothelial cells may have a differential effect on human melanoma cells expressing different degrees of aggressiveness.(9) In this manner endothelial derived cytokines could conceivably contribute to tumor progression by suppressing the growth of the less aggressive tumor cells and promoting dominance of their malignant counterparts in 'strategic' perivascular zones. Distinct biological features expressed by tumor-associated vasculature may serve as potential prognostic markers of disease progression as well as novel targets for therapeutic intervention.
引用
收藏
页码:3 / 18
页数:16
相关论文
共 161 条
[51]  
FOULDS L, 1969, NEOPLASTIC DEV
[52]  
FOX SB, 1993, CANCER RES, V53, P4161
[53]  
FRANKFURT OS, 1991, CANCER RES, V51, P1190
[54]   A TUMOR SUPPRESSOR-DEPENDENT INHIBITOR OF ANGIOGENESIS IS IMMUNOLOGICALLY AND FUNCTIONALLY INDISTINGUISHABLE FROM A FRAGMENT OF THROMBOSPONDIN [J].
GOOD, DJ ;
POLVERINI, PJ ;
RASTINEJAD, F ;
LEBEAU, MM ;
LEMONS, RS ;
FRAZIER, WA ;
BOUCK, NP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6624-6628
[55]  
GRAHAM CH, 1994, UNPUB AM J PATHOL
[56]   THE FPS/FES PROTEIN-TYROSINE KINASE PROMOTES ANGIOGENESIS IN TRANSGENIC MICE [J].
GREER, P ;
HAIGH, J ;
MBAMALU, G ;
KHOO, W ;
BERNSTEIN, A ;
PAWSON, T .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6755-6763
[57]  
GROMET MA, 1978, CANCER-AM CANCER SOC, V42, P2282, DOI 10.1002/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO
[58]  
2-V
[59]   ANGIOGENESIS AND RISK OF BREAST-CANCER IN WOMEN WITH FIBROCYSTIC DISEASE [J].
GUINEBRETIERE, JM ;
LEMONIQUE, G ;
GAVOILLE, A ;
BAHI, J ;
CONTESSO, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (08) :635-636
[60]   A MONOCLONAL-ANTIBODY REACTING WITH ENDOTHELIAL-CELLS OF BUDDING VESSELS IN TUMORS AND INFLAMMATORY TISSUES, AND NONREACTIVE WITH NORMAL ADULT TISSUES [J].
HAGEMEIER, HH ;
VOLLMER, E ;
GOERDT, S ;
SCHULZEOSTHOFF, K ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (04) :481-488